Dr. Ekaterina Rogaeva obtained her PhD from Moscow State University in 1988. Since 1992, she has been conducting genetic research at the University of Toronto and became a Full Professor in 2015. She has contributed to 460 papers (h-index=103), primarily focused on the development of effective genetic testing for neurodegenerative diseases (e.g., ALS, Alzheimer’s, and Parkinson’s diseases). For instance, she played a central role in the discovery of genes responsible for Alzheimer’s disease (e.g., PSEN1, PSEN2, and SORL1). More recently, her research has focused on the link between neurodegenerative disorders and epigenetic events, including age-related DNA methylation that reflects biological aging.